CorMedix Inc.
Biopharma firm developing therapeutics for infectious and inflammatory diseases.
CRMD | US
Overview
Corporate Details
- ISIN(s):
- US21900C3088
- LEI:
- Country:
- United States of America
- Address:
- 300 CONNELL DRIVE, 7922 BERKELEY HEIGHTS
- Website:
- https://cormedix.com/
- Sector:
- Manufacturing
Description
CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening infectious and inflammatory diseases. The company's principal product is DefenCath® (taurolidine and heparin), an antimicrobial and antifungal catheter lock solution. It is approved to reduce the incidence of catheter-related bloodstream infections (CRBSIs) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. In addition to DefenCath, CorMedix's early-stage research includes exploring the potential of taurolidine for cancer treatment, particularly in pediatric neuroblastoma, and for other antimicrobial and anti-inflammatory applications.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all CorMedix Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CorMedix Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CorMedix Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
